Your browser doesn't support javascript.
loading
Safety of BNT162b2 mRNA COVID-19 vaccine in a cohort of elderly, immunocompromised patients with systemic vasculitis.
Delvino, Paolo; Bozzalla-Cassione, Emanuele; Biglia, Alessandro; Quadrelli, Verdiana Serena; Bartoletti, Alice; Montecucco, Carlomaurizio; Monti, Sara.
Afiliação
  • Delvino P; Rheumatology Department, IRCCS Policlinico S. Matteo Foundation, University of Pavia, and PhD in Experimental Medicine, University of Pavia, Italy. paolo.delvino01@universitadipavia.it.
  • Bozzalla-Cassione E; Rheumatology Department, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Italy.
  • Biglia A; Rheumatology Department, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Italy.
  • Quadrelli VS; Rheumatology Department, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Italy.
  • Bartoletti A; Rheumatology Department, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Italy.
  • Montecucco C; Rheumatology Department, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Italy.
  • Monti S; Rheumatology Department, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Italy.
Clin Exp Rheumatol ; 40(4): 853, 2022 05.
Article em En | MEDLINE | ID: mdl-34528506
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vasculite Sistêmica / COVID-19 / Vacina BNT162 Limite: Aged / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vasculite Sistêmica / COVID-19 / Vacina BNT162 Limite: Aged / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article